Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells

Riferimento: 
Brain Res. 2012 May 15;1454:1-13.
Autori: 
Chakrabarti M, Khandkar M, Banik NL, Ray SK.
Fonte: 
Brain Res. 2012 May 15;1454:1-13.
Anno: 
2012
Azione: 
Alterazioni nella espressione di specifici microRNA oncogenici (OGmiRs) e miR-soppressori tumorali (TSmiRs) di N-(4-idrossifenil) retinamide (4-HPR) e (-)-epigallocatechina-3-gallato (EGCG) inibiscono la crescita dei neuroblastomi maligni.
Target: 
4-HPR – EGCG/neuroblastoma maligno.

ABSTRACT
Malignant neuroblastomas are childhood tumors that remain mostly incurable. We explored efficacy of N-(4-hydroxyphenyl) retinamide (4-HPR) and (-)-epigallocatechin-3-gallate (EGCG) in altering expression of oncogenic microRNAs (OGmiRs) and tumor suppressor miRs (TSmiRs) for controlling growth of human malignant neuroblastoma SK-N-BE2 and IMR-32 cells. Combination of 4-HPR and EGCG most significantly decreased expression of OGmiRs (miR-92, miR-93, and miR-106b) and increased expression of TSmiRs (miR-7-1, miR-34a, and miR-99a) in both cell lines. Overexpression of miR-93 and miR-7-1, respectively, decreased and increased efficacy of treatments. Thus, alterations in expression of specific OGmiRs and TSmiRs by 4-HPR and EGCG inhibited growth of malignant neuroblastomas.
Free PMC Article

 

Sostanze: